Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,429 | 402 | -9,522 | 2,771 | 2,084 |
| Depreciation Amortization | 1,389 | 1,043 | 1,732 | 1,825 | 1,383 |
| Income taxes - deferred | -2,819 | -309 | -6,750 | -1,732 | -1,646 |
| Accounts receivable | -406 | -2,000 | -1,569 | -1,720 | 533 |
| Accounts payable and accrued liabilities | 1,000 | -424 | 689 | 116 | 532 |
| Other Working Capital | 2,838 | 3,698 | 5,985 | 4,250 | 4,857 |
| Other Operating Activity | 5,905 | 3,600 | 18,354 | 3,063 | 184 |
| Operating Cash Flow | $5,479 | $6,011 | $8,920 | $8,573 | $7,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -116 | -2,404 | -6,839 | -10,299 | -1,834 |
| Purchase Of Investment | -3,648 | -2,891 | -1,083 | -1,142 | N/A |
| Sale Of Investment | 2,788 | 1,618 | 577 | 1,161 | N/A |
| Purchase Sale Intangibles | N/A | -1,200 | -800 | -5,000 | -5,117 |
| Other Investing Activity | 0 | -1,200 | -800 | -5,000 | -5,117 |
| Investing Cash Flow | $-975 | $-4,877 | $-8,145 | $-15,280 | $-6,951 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,800 | 5,220 | 950 | 16,633 | N/A |
| Debt Repayment | -148 | -136 | -156 | -1,947 | -4,100 |
| Common Stock Issued | 23 | 76 | N/A | 551 | 1,276 |
| Common Stock Repurchased | -170 | -1,424 | -799 | -1,820 | -249 |
| Dividend Paid | -3,231 | -2,021 | N/A | -7,673 | N/A |
| Other Financing Activity | -10,020 | -2,695 | -2,068 | -5,597 | 0 |
| Financing Cash Flow | $-4,745 | $-979 | $-2,073 | $148 | $-3,073 |
| Beginning Cash Position | 561 | 406 | 1,704 | 8,263 | 10,361 |
| End Cash Position | 319 | 561 | 406 | 1,704 | 8,263 |
| Net Cash Flow | $-242 | $155 | $-1,298 | $-6,559 | $-2,098 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,479 | 6,011 | 8,920 | 8,573 | 7,926 |
| Capital Expenditure | -231 | -2,404 | -6,839 | -12,169 | -1,834 |
| Free Cash Flow | 5,248 | 3,607 | 2,081 | -3,596 | 6,092 |